Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading down 5 points (0.0%) at 16,932 as of Tuesday, June 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,934 issues advancing vs. 1,059 declining with 170 unchanged. The Financial Services industry currently sits up 0.1% versus the S&P 500, which is up 0.2%. On the negative front, top decliners within the industry include Sabine Royalty ( SBR), down 5.4%, Altisource Asset Management ( AAMC), down 4.9%, NASDAQ OMX Group ( NDAQ), down 2.0% and Apollo Global Management ( APO), down 0.9%. Top gainers within the industry include Janus Capital Group ( JNS), up 2.3%, Artisan Partners Asset Management ( APAM), up 2.0%, Total System Services ( TSS), up 1.0%, Eaton Vance ( EV), up 1.0% and Voya Financial ( VOYA), up 0.8%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. CME Group ( CME) is one of the companies pushing the Financial Services industry lower today. As of noon trading, CME Group is down $0.84 (-1.2%) to $71.35 on light volume. Thus far, 450,438 shares of CME Group exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $71.05-$72.00 after having opened the day at $71.88 as compared to the previous trading day's close of $72.19. CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group has a market cap of $24.1 billion and is part of the financial sector. Shares are down 8.0% year-to-date as of the close of trading on Monday. Currently there are 7 analysts that rate CME Group a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, reasonable valuation levels, expanding profit margins and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full CME Group Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.